FTIDC
CAS: 873551-53-2
Ref. 3D-YJB55153
| 1mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued |
Product Information
FTIDC is a potent antiviral compound that contains inositol, an essential nutrient for cellular function. It has been shown to inhibit the replication of viruses such as MDA-MB-231 and has high bioavailability, making it an effective treatment option. FTIDC works by forming hydrogen bonds with prostacyclin compounds, which are biochemicals involved in various cellular processes. This interaction disrupts viral replication and prevents the spread of infection. Additionally, FTIDC acts as a prostacyclin analogue, mimicking the effects of epoprostenol, a naturally occurring prostacyclin. This compound also exhibits alkaloid-like properties similar to carbamazepine and tenofovir. With its unique combination of antiviral and biochemical properties, FTIDC offers promising potential in the field of research chemicals.
